C.RIVESIN — DEVELOPMENT AND REGISTRATION OF A MEDICINAL PRODUCT FOR HUMAN USE, FOR RARE DISEASES: TREATMENT OF INTERSTITAL CYSTITIS, FOR ITS DISTRIBUTION ON THE EUROPEAN UNION. (Q2043648): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
||
Property / financed by | |||
Property / financed by: Directorate-General for Regional and Urban Policy / rank | |||
Revision as of 09:39, 2 November 2020
Project Q2043648 in Italy
Language | Label | Description | Also known as |
---|---|---|---|
English | C.RIVESIN — DEVELOPMENT AND REGISTRATION OF A MEDICINAL PRODUCT FOR HUMAN USE, FOR RARE DISEASES: TREATMENT OF INTERSTITAL CYSTITIS, FOR ITS DISTRIBUTION ON THE EUROPEAN UNION. |
Project Q2043648 in Italy |
Statements
15,000.0 Euro
0 references
30,000.0 Euro
0 references
50.0 percent
0 references
18 July 2017
0 references
14 April 2018
0 references
23 October 2017
0 references
NEXTRARESEARCH SOCIETA' A RESPONSABILITA' LIMITATA
0 references
C.RIVESTIN - DEVELOPMENT AND REGISTRATION OF A MEDICINAL PRODUCT FOR HUMAN USE, FOR RARE DISEASE: TREATMENT OF INTERSTITIAL CYSTITIS, FOR ITS DISTRIBUTION ON THE EUROPEAN UNION. (Italian)
0 references
C.RIVESIN — DEVELOPMENT AND REGISTRATION OF A MEDICINAL PRODUCT FOR HUMAN USE, FOR RARE DISEASES: TREATMENT OF INTERSTITAL CYSTITIS, FOR ITS DISTRIBUTION ON THE EUROPEAN UNION. (English)
0 references
Identifiers
E47F17001680002
0 references